Poly (ADP-ribose) polymerase (PARP) inhibitor regimens for ovarian cancer in phase III randomized controlled trials: a network meta-analysis
Han Gong, Dan Nie, Yue Huang, Zhengyu Li
International Journal of Gynecologic Cancer Oct 2020, 30 (10) 1576-1582; DOI: 10.1136/ijgc-2020-001373